Caldwell G, Gow S M, Sweeting V M, Beckett G J, Seth J, Toft A D
Clin Chem. 1987 Feb;33(2 Pt 1):303-5.
Using a highly sensitive and specific immunoradiometric assay for thyrotropin, we studied thyrotroph function in 232 new patients referred to a thyroid clinic and in 13 patients after treatment for hyperthyroidism. Significant thyrotroph responsiveness to thyroliberin (thyrotropin-releasing hormone, TRH) was found in all patients with values for basal thyrotropin greater than 0.1 milli-int unit/L. In no overtly hyperthyroid patient was any increment in thyrotropin recorded at 20 min after thyroliberin administration. In seven patients, four subclinically hyperthyroid and three who had received treatment, increments in thyrotropin from undetectable basal values were recorded, consistent with incomplete thyrotroph suppression. By use of assays with even higher sensitivity, one may be able to distinguish these patients from overtly hyperthyroid patients.
我们使用一种高度灵敏且特异的促甲状腺激素免疫放射测定法,对转诊至甲状腺门诊的232例新患者以及13例甲亢治疗后的患者进行了促甲状腺细胞功能研究。在所有基础促甲状腺激素值大于0.1毫国际单位/升的患者中,均发现促甲状腺细胞对促甲状腺素释放激素(TRH)有显著反应。在给予促甲状腺素释放激素后20分钟,未发现任何明显甲亢患者的促甲状腺激素有升高。在7例患者中,4例亚临床甲亢患者和3例接受过治疗的患者,促甲状腺激素从不可检测的基础值升高,这与促甲状腺细胞抑制不完全一致。通过使用灵敏度更高的检测方法,或许能够将这些患者与明显甲亢患者区分开来。